We are Morrison & Foerster. We are MoFo. We are synonymous with a commitment to client service and advisors to market-changing deals and impact litigation. Our clients include some of the largest financial institutions, Fortune 100 companies, and leading technology and life sciences companies. We represent investment funds and startup companies, and over the years have supported their growth and development as leading industry players and household brands.
Subscribe:.rss.atom.json.md.m3u.pls
Live Last read · last published · next check
Saves to your Listen queue, to pick up on another day or another device.
Morrison Foerster partners Kate Driscoll and Nate Mendell, both former federal prosecutors and members of the firm’s Investigations + White Collar Defense Group, hosted the thirteenth episode of When Your Life Sciences Are on the Line, where leading practitioners and thought leaders share the insights and advice needed to manage business and legal risk in the life sciences sector.
In this episode of the Above Board podcast, hosts Scott Lesmes and Haima Marlier are joined by Morrison Foerster partners Trevor Levine and Ryan Adams to examine the rapid rise of prediction markets and the governance, compliance, and enforcement questions they raise for public companies. Trevor explains how prediction markets operate, why they fall under CFTC jurisdiction, and the regulatory…
In this episode of our Data, Cyber + Privacy PLUS podcast, hosts Kaylee Cox Bankston and Boris Segalis continue their conversation with Georgina Merhom, data scientist and founder of SOLO. They explore the structural gaps in today’s financial data ecosystem, the importance of data traceability, and how evolving ownership models are reshaping the economics of data.
Scott Lesmes and Haima Marlier are joined by Morrison Foerster Securities Litigation partners Jamie Levitt and Ryan Keats to discuss what public companies can expect in securities litigation and enforcement in 2026.
The 25th episode in this series focuses on “Looking Ahead: What’s Next for Responsible Business in 2026,” featuring Aron Cramer, President and CEO of BSR, in conversation with Suz Mac Cormac, co-chair of the Sustainability + Corporate Responsibility and Social Enterprise + Impact Investing practices at Morrison Foerster.
Morrison Foerster partners Kate Driscoll and Nate Mendell, both former federal prosecutors and members of the firm’s Investigations + White Collar Defense Group, hosted the twelfth episode of When Your Life Sciences Are on the Line, where leading practitioners and thought leaders share the insights and advice needed to manage business and legal risk in the life sciences sector. In this episode,…
In this episode, hosts Kaylee Cox Bankston and Boris Segalis discuss their latest favorite uses of AI and the new CCPA developments before sitting down with Georgina Merhom, data scientist and founder of Solo, for the first installment of a two-part conversation exploring the foundations of trustworthy data and AI in financial services.
In this episode of our Data, Cyber + Privacy PLUS podcast, hosts Kaylee Cox Bankston and Boris Segalis sit down with Carrie Cordero, General Counsel and Robert M. Gates Senior Fellow at the Center for a New American Security, for a thought-provoking conversation about the emerging AI regulatory landscape, the bipartisan push to strengthen cybersecurity, and the growing influence of private-sector…
The 24th episode in this series focuses on a “2025 Climate Week NYC Debrief,” featuring Helen Clarkson, CEO of Climate Group, in conversation with Aron Cramer, President and CEO of BSR. Helen and Aron provide their insights on a debriefing of the events of Climate Week NYC 2025. Their discussion also delves into actionable insights and innovative approaches to sustainability, with a particular…
Morrison Foerster partners Kate Driscoll and Nate Mendell, both former federal prosecutors and members of the firm’s Investigations + White Collar Defense Group, hosted the eleventh episode of When Your Life Sciences Are on the Line, where leading practitioners and thought leaders share the insights and advice needed to manage business and legal risk in the life sciences sector.
